Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Ma

Showing results (741-750 of 864) with videos related to

Pageof 87
Sort By:
Pacing and Clinical Electrophysiology : PACE|September 16, 2022
Repeat ablation strategy for recurrent persistent atrial fibrillation: A propensity-matched score comparison between "2C3L" and "extensive ablation" approachJing Lin, Chen-Xi Jiang, De-Yong Long, et al.
Journal of Thrombosis and Thrombolysis|October 22, 2021
Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndromeWen-He Lv, Jian-Zeng Dong, Xin Du, et al.
Pacing and Clinical Electrophysiology : PACE|January 25, 2014
Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome?Ying-Wei Chen, Rong Bai, Tao Lin, et al.
American Heart Journal|December 7, 2019
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry programMichał Mazurek, Christine Teutsch, Hans-Christoph Diener, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 10, 2021
Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AFSake J van der Wall, Christine Teutsch, Sergio J Dubner, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 10, 2018
Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control StudyZhi-Zhao Li, Xin Du, Xue-Yuan Guo, et al.
Chinese Medical Journal|September 8, 2010
Prognostic value of baseline C-reactive protein levels in patients undergoing coronary revascularizationXu Li, Xiao-Hui Liu, Shao-Ping Nie, et al.
ESC Heart Failure|July 3, 2020
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AFSergio J Dubner, Christine Teutsch, Menno V Huisman, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 20, 2016
Plasma homocysteine levels predict early recurrence after catheter ablation of persistent atrial fibrillationYan Yao, Wei Yao, Rong Bai, et al.
Heart Rhythm|June 19, 2016
Ridge-related reentry despite apparent bidirectional mitral isthmus blockChen-Xi Jiang, Jian-Zeng Dong, De-Yong Long, et al.
Pageof 87

Showing results (741-750 of 864) with videos related to

Sort By:
Pageof 87
Pacing and Clinical Electrophysiology : PACE|September 16, 2022
Repeat ablation strategy for recurrent persistent atrial fibrillation: A propensity-matched score comparison between "2C3L" and "extensive ablation" approachJing Lin, Chen-Xi Jiang, De-Yong Long, et al.
Journal of Thrombosis and Thrombolysis|October 22, 2021
Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndromeWen-He Lv, Jian-Zeng Dong, Xin Du, et al.
Pacing and Clinical Electrophysiology : PACE|January 25, 2014
Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome?Ying-Wei Chen, Rong Bai, Tao Lin, et al.
American Heart Journal|December 7, 2019
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry programMichał Mazurek, Christine Teutsch, Hans-Christoph Diener, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 10, 2021
Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AFSake J van der Wall, Christine Teutsch, Sergio J Dubner, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 10, 2018
Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control StudyZhi-Zhao Li, Xin Du, Xue-Yuan Guo, et al.
Chinese Medical Journal|September 8, 2010
Prognostic value of baseline C-reactive protein levels in patients undergoing coronary revascularizationXu Li, Xiao-Hui Liu, Shao-Ping Nie, et al.
ESC Heart Failure|July 3, 2020
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AFSergio J Dubner, Christine Teutsch, Menno V Huisman, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 20, 2016
Plasma homocysteine levels predict early recurrence after catheter ablation of persistent atrial fibrillationYan Yao, Wei Yao, Rong Bai, et al.
Heart Rhythm|June 19, 2016
Ridge-related reentry despite apparent bidirectional mitral isthmus blockChen-Xi Jiang, Jian-Zeng Dong, De-Yong Long, et al.
Pageof 87